Topics

Arca Biopharma rockets after ‘encouraging’ data for beta-blocker Gencaro

10:45 EDT 2 May 2019 | Proactive Investors

Dr Jonathan P Piccini, the lead author of the paper, said the data is ‘very encouraging’ and merited further investigation in future Phase 3 trials

Original Article: Arca Biopharma rockets after ‘encouraging’ data for beta-blocker Gencaro

NEXT ARTICLE

More From BioPortfolio on "Arca Biopharma rockets after ‘encouraging’ data for beta-blocker Gencaro"

Quick Search